Cell-targeting vector selective for T lymphocytes, useful in gene therapy of e.g. acquired immune deficiency syndrome, encodes a single-chain variable antibody fragment

摘要

A cell-targeting vector (A) containing a DNA sequence (I) encoding a single-chain variable antibody fragment (scFv) that has a 329, 309, 330, 315 or 302 residue amino acid sequence, all fully defined in the specification, is new. An Independent claim is also included for a pharmaceutical composition containing (A).